« House Backs Biotech Tax Breaks | Main | Pfizer Does Another Academic Development Deal With UCSD »

08/08/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b014e8a7bd608970d

Listed below are links to weblogs that reference FDA BioSimilar Rules Tilt Us Toward BioBetters?:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

An analysis from the Patent Doc blog that asserts interchangeability of biosimilars will not be possible before 2020.
http://www.patentdocs.org/2011/08/fda-looks-to-multiple-sources-including-ema-guidelines-in-developing-biosimilar-approval-standards.html

bigredbruce

More on this from the BioProcess Blog
http://www.bioprocessblog.com/archives/300

bigredbruce

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada